Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Are A2 Milk (ASX:A2M) shares too good to miss?

A2 Milk Company Ltd (ASX: A2M) has released an investor presentation today. Are A2 Milk shares too good to miss?

A2 Milk’s presentation

A2 Milk is presenting at the CLSA Investor Forum.

The infant formula business reminded investors of its strong performance in FY20. Total revenue grew by 32.8% to NZ$1.73 billion. EBITDA (click here to learn what EBITDA means) grew by 32.9% to NZ$549.7 million and net profit after tax (NPAT) increased by 34.1% to NZ$385.8 million.

It was its overseas growth that was particularly impressive. China label infant nutrition sales more than doubled to NZ$337.7 million with distribution increasing to 19,100 stores. In the US revenue increased 91.2% and distribution rose to 20,300 stores.

A2 Milk said that it estimates that COVID-19 had a modest positive impact in FY20 on both revenue and EBITDA. During FY20 in China there was a home-delivery service launched, though there was a softening of retail daigou due to reduced tourism from China and international student numbers.

The company is expecting an unwinding of pantry stocking in the early part of FY21. The corporate daigou and reseller channel has been disrupted due to stage 4 lockdowns in Victoria.

However, A2 Milk remains focused on its one brand, two labels strategy. Its China label range delivers its ‘super premium’ positioning, particularly in higher tier cities and mother and baby stores. The English label product has premium pricing within the reseller and online channels, it’s more accessible for some consumers.

China based channels now account for 48% of total infant nutrition sales. A2 Milk said in this presentation that it’s executing on its strategy with a 2% market share in mother and baby stores. Management believe it has a “significant opportunity for further growth.”

Outlook

A2 Milk reminded investors it generated NZ$427.4 million of operating cash flow in FY20 and it had a closing cash balance of NZ$854.2 million.

The company is undertaking a number of growth initiatives including investing in manufacturing. This will mitigate risk with supplier and geographic diversification. The newly commissioned plant can produce the highest quality products.

It’s planning to launch new products into existing markets and expand its current product range into new markets.

A2 Milk also said it’s assessing complementary acquisitions to drive its growth in its core markets.

It’s planning to maintain a conservative balance sheet, however, excess cashflow will be used for shareholder returns. That’s an encouraging signal for investors.

The company is still expecting strong revenue growth. But it noted that COVID-19 uncertainties and COVID-19 impacts could hurt demand and hurt the supply chain.

Summary

I think A2 Milk is one of the best ASX growth shares, it would be one of the first ASX 200 shares I’d buy today.

I reckon the infant formula industry still has a lot of growth potential, which is why I also like Bubs Australia Ltd (ASX: BUB). But tech shares also have strong growth potential – I wrote about Redbubble Ltd (ASX: RBL) and Pushpay Holdings Ltd (ASX: PPH) in this article.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, the author of this article does not have a financial or commercial interest in any of the companies mentioned.
Skip to content